As expected, the inhibitory effects of Trim44 KO on pathological cardiac hypertrophy induced by ISO treatment were exerted by suppressing the AKT/mTOR/GSK3β/P70S6K signaling pathway. The gene discussed is TRIM44; the disease is cardiac hypertrophy.